Skip to main content
Smart Investors Daily
GD

NASDAQ · GDRX

GoodRx Holdings, Inc.

Healthcare · Medical - Healthcare Information Services

$3.45

Down-$0.11 (-3.09%)

Updated Aug 22, 2026, 8:57 AM

SID Score

5.2/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
946.49M
P/E ratio
23.18
Dividend yield
0.00%
52-week range
$1.77 – $5.81
Volume
1.75M
Avg. volume
3.68M

Price performance

GDRX price history

1M range · 21 trading sessions · Daily adjusted prices

GDRX closed at $3.45 after 21 trading sessions, up 16.55% for the selected period.

Last close
$3.45
Period change
+16.55%
Period low
$2.96
Period high
$3.80
Daily close
View OHLC price history
GDRX OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 21, 2026$3.60$3.60$3.44$3.451.75M
Aug 20, 2026$3.49$3.59$3.461$3.562.72M
Aug 19, 2026$3.58$3.595$3.455$3.543.77M
Aug 18, 2026$3.70$3.79$3.645$3.651.09M
Aug 17, 2026$3.69$3.7409$3.655$3.721.31M
Aug 14, 2026$3.72$3.75$3.635$3.731.85M
Aug 13, 2026$3.58$3.73$3.54$3.721.21M
Aug 12, 2026$3.79$3.81$3.565$3.591.6M
Aug 11, 2026$3.67$3.89$3.665$3.801.92M
Aug 10, 2026$3.63$3.86$3.57$3.662.48M
Aug 7, 2026$3.78$3.845$3.635$3.681.91M
Aug 6, 2026$3.42$3.82$3.23$3.724.4M
Aug 5, 2026$3.33$3.36$3.215$3.272.17M
Aug 4, 2026$3.12$3.405$3.12$3.342.76M
Aug 3, 2026$3.15$3.239$3.14$3.16769.89K
Jul 31, 2026$3.17$3.17$3.06$3.07712.65K
Jul 30, 2026$3.22$3.25$3.01$3.172.07M
Jul 29, 2026$3.10$3.305$3.10$3.221.55M
Jul 28, 2026$3.06$3.1488$3.05$3.12789.07K
Jul 27, 2026$3.00$3.095$2.9608$3.051.06M
Jul 24, 2026$2.89$2.965$2.84$2.96530.54K

Latest GDRX news

The latest Smart Investors Daily articles mentioning GDRX.

GDRX research

Overview

Company profile and research snapshot.

Company profile

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
$4.50
Implied upside
Analysts
GDRX recent ratings
DateFirmRatingTarget
Aug 21, 2026BarclaysUnderweight
Aug 13, 2026UBSNeutral
Aug 11, 2026CitigroupBuy
Aug 11, 2026TD CowenBuy
Aug 7, 2026Wells FargoOverweight
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Jun 25, 2026

[Latest] Global Healthcare Discount Plan Market Size/Share Worth USD 48.37 Billion by 2035 at a 8.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Healthcare Discount Plan Market size & share revenue was valued at approximately USD 18.64 Billion in 2025 and is expected to reach USD 20.84 Billion in 2026 and is expected to reach around USD 48.37 Billion by 2035, at a CAGR of 8.8% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are GoodRx Holdings Inc.,

Yahoo · Jun 25, 2026

2 Healthcare Stocks to Consider Right Now and 1 We Brush Off

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately - over the past six months, healthcare stocks have gained 7.6%, nearly mirroring the S&P 500.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.